nvCJD Donor Plasma Product Market Withdrawal Is "Prudent" - EMEA
Executive Summary
Medicinal products derived from blood or plasma of donors believed to have new variant Creutzfeldt-Jakob Disease should be withdrawn from the market, the European Medicines Evaluation Agency Committee on Proprietary Medicinal Products recommended Feb. 25.